Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Dexamethasone for Chronic Subdural Hematoma in Patients with Coagulation Disorders
NCT02192320Phase 2Unknown
- Sponsor
- Oriental Neurosurgery Evidence-Based-Study Team
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in chronic subdural hematoma (CSDH), sponsored by Oriental Neurosurgery Evidence-Based-Study Team. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT02192320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192320.